FDA Grants Emergency Approval for RSV Preventive Antibody for High-Risk Infants Amid Record Winter Surge
FDA approves nirsevimab, a monoclonal antibody RSV preventive for high-risk infants, as…
FDA Approves Groundbreaking RSV Vaccine for Infants Under 6 Months Amid Record Winter Surge
FDA emergency approves new RSV vaccine for infants under 6 months as…
